IIM
RLMD icon

INTECH Investment Management’s Relmada Therapeutics RLMD Stock Holding History

INTECH Investment Management’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136K Buy
+19,720
New +$138K ﹤0.01% 1884

Other funds holding RLMD

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

INTECH Investment Management's RLMD Position: Q2 2026 in Review

INTECH Investment Management opened a new position in Relmada Therapeutics (RLMD) in Q2 2026: 19,720 shares worth $136K. The stake represents ﹤0.01% of the portfolio and ranks #1884 among its holdings.

126 funds tracked by Wall St. Rank hold RLMD as of Q2 2026.

  • INTECH Investment Management held 19,720 shares of Relmada Therapeutics worth $136K as of Q2 2026.
  • Relmada Therapeutics was a new INTECH Investment Management position in Q2 2026.
  • Relmada Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1884 holding.
  • 126 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.